Navigation Links
Regenicin to Form Scientific Advisory Board
Date:10/19/2010

NEW YORK Oct. 19 /PRNewswire-FirstCall/ -- Regenicin, Inc. (OTC Bulletin Board: WDST), a development stage biotechnology company, announced today that they have begun identifying candidates for the formation of a Scientific Advisory Board.  The board will include thought leaders, scientists and physicians in the fields of regenerative medicine, cellular biology, dermatology and burn and wound treatment. Appointees will play a key role in advising Regenicin on the company's current and future research and development programs as well as in corporate strategies for global expansion.

"We look forward to assembling a team that can provide objective feedback and guidance on Regenicin's efforts to develop and deliver breakthrough treatments for chronic burns and wounds," says Randall McCoy, CEO of Regenicin. "Currently we have identified our key candidates and will announce them individually upon full approval by our board of directors." Regenicin expects to have the full Scientific Advisory Board is in place within the next ninety days.

About Regenicin, Inc.

Regenicin, Inc. is a development stage company focusing on next-generation tissue-engineered skin substitutes to restore the qualities of healthy human skin. Regenicin is a publicly traded company, with headquarters in Little Falls, NJ. Additional information can be found in the company's filings with the Securities and Exchange Commission located at www.sec.gov.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Regenicin(TM), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Regenicin Names Former U.S. Marine Corp Operations Officer, Christopher Hadsall, Chief Operating Officer
2. Former Fujifilm Medical Systems USA Executive John J. Weber Agrees to Join Regenicin™ as a Member of Its Board of Directors and Interim CFO
3. Regenicin Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville
4. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
5. Glencoe Software and The Journal of Cell Biology Pioneer Online Publishing of Scientific Image Data: New Version of JCB DataViewer Released
6. Orexigen® Therapeutics Announces Upcoming Data Presentations at the 28th Annual Scientific Meeting of The Obesity Society
7. Pepscan Therapeutics Announces Establishment of Scientific Advisory Board
8. Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level
9. Metamark Genetics, Inc. Announces New Chief Scientific Officer
10. Fibrocell Science, Inc. Names Biotechnology and Genetic Research Expert Stefan Gruenwald, M.D., Ph.D., to Scientific Advisory Board
11. American Humane Association Announces Joy Mench, Ph.D., Joins the Scientific Advisory Committee of the American Humane Certified® Farm Animal Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... ... May 17, 2017 , ... ... compliance and commercialization, has just released version 9.0 of the Cognition Cockpit platform. ... version of Cockpit,” says David Cronin, CEO of Cognition. “We’re thrilled to finally ...
(Date:5/18/2017)... ... May 17, 2017 , ... HOLLOWAY AMERICA, a leading ... and dairy, munitions, and pharmaceutical/biotech, recently introduced The Revolution Lift™, a new precision-controlled ... improvement in technology comes on the heels of HOLLOWAY’s release of the intelliVessel™, ...
(Date:5/18/2017)... ... May 17, 2017 , ... Many complicated ... likely to develop Alzheimer’s disease, while men are at greater risk for Parkinson’s ... neuronal bias is the aim of a research program at Worcester Polytechnic Institute ...
(Date:5/16/2017)... Switzerland (PRWEB) , ... May 16, 2017 , ... ... R&D, today announced its global Genedata Screener User Group Meetings, which ... Screener users the opportunity to share best practices in screening data analysis and ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition ... their offering. ... tracking market to grow at a CAGR of 30.37% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
Breaking Biology News(10 mins):